Wessel TC - Search Results

1

Erythropoietin therapy for acute stroke is both safe and beneficial.

Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Rüther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Sirén AL. Ehrenreich H, et al. Among authors: wessel tc. Mol Med. 2002 Aug;8(8):495-505. Mol Med. 2002. PMID: 12435860 Free PMC article. Clinical Trial.

2

Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.

Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, Koudstaal PJ, Wessel T. Diener HC, et al. Stroke. 2000 Nov;31(11):2543-51. doi: 10.1161/01.str.31.11.2543. Stroke. 2000. PMID: 11062273 Clinical Trial.

3

Nitrous oxide modulator: lubeluzole.

Diener HC, Wessel TC. Diener HC, et al. Among authors: wessel tc. Curr Med Res Opin. 2002;18 Suppl 2:s23-6. doi: 10.1185/030079902125000697. Curr Med Res Opin. 2002. PMID: 12365825

4

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D. Rockwood K, et al. J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95. doi: 10.1136/jnnp.71.5.589. J Neurol Neurosurg Psychiatry. 2001. PMID: 11606667 Free PMC article. Clinical Trial.

5

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T. Krystal AD, et al. Among authors: wessel tc. Sleep. 2003 Nov 1;26(7):793-9. doi: 10.1093/sleep/26.7.793. Sleep. 2003. PMID: 14655910 Clinical Trial.

6

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

Raskind MA, Peskind ER, Wessel T, Yuan W. Raskind MA, et al. Neurology. 2000 Jun 27;54(12):2261-8. doi: 10.1212/wnl.54.12.2261. Neurology. 2000. PMID: 10881250 Clinical Trial.

7

REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.

Fava M, Stahl S, Pani L, De Martin S, Pappagallo M, Guidetti C, Alimonti A, Bettini E, Mangano RM, Wessel T, de Somer M, Caron J, Vitolo OV, DiGuglielmo GR, Gilbert A, Mehta H, Kearney M, Mattarei A, Gentilucci M, Folli F, Traversa S, Inturrisi CE, Manfredi PL. Fava M, et al. Am J Psychiatry. 2022 Feb;179(2):122-131. doi: 10.1176/appi.ajp.2021.21020197. Epub 2021 Dec 22. Am J Psychiatry. 2022. PMID: 34933568 Clinical Trial.

8

A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.

Scharf M, Erman M, Rosenberg R, Seiden D, McCall WV, Amato D, Wessel TC. Scharf M, et al. Among authors: wessel tc. Sleep. 2005 Jun;28(6):720-7. doi: 10.1093/sleep/28.6.720. Sleep. 2005. PMID: 16477959 Clinical Trial.

9

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.

Krystal A, Fava M, Rubens R, Wessel T, Caron J, Wilson P, Roth T, McCall WV. Krystal A, et al. J Clin Sleep Med. 2007 Feb 15;3(1):48-55. J Clin Sleep Med. 2007. PMID: 17557453 Clinical Trial.

10

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.

Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK. Erman MK, et al. J Clin Sleep Med. 2008 Jun 15;4(3):229-34. J Clin Sleep Med. 2008. PMID: 18595435 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page